Stay updated on Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial page.

Latest updates to the Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial page
- Check2 days agoChange DetectedThe page’s footer/site build revision was updated from v3.5.2 to v3.5.3, indicating a minor site version change without changing the underlying ClinicalTrials.gov study details.SummaryDifference0.0%

- Check9 days agoChange DetectedAdded Revision: v3.5.2; removed Schizophrenia, related topics:, MedlinePlus Genetics, and Revision: v3.5.0.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedSchizophrenia has been added as a topic. The related topic MedlinePlus Genetics has been added as well.SummaryDifference0.1%

- Check31 days agoChange DetectedDeleted references to Schizophrenia and the MedlinePlus Genetics related topics section from the page.SummaryDifference0.1%

- Check38 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check45 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the page, reflecting a site revision update. No study-specific data or outcomes appear to be changed.SummaryDifference0.0%

Stay in the know with updates to Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing 15 vs 30 mg CVL-231 in Schizophrenia Clinical Trial page.